Akihiro Kawauchi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Akihiro Kawauchi has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
Tsuneharu Miki
Department of Urology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
14 shared publications- Tsuneharu Miki
Departments of Translational Cancer Drug Development and Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan
13 shared publications Yoichi Mizutani
13 shared publicationsJintetsu Soh
Department of Urology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
12 shared publicationsAkira Fujito
8 shared publicationsYasuyuki Naitoh
Department of Urology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
8 shared publications
Latest Publications
- 10 February 2012
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 30 (5) , 85
Skeletal events unrelated to bone metastasis in men with castration-refractory prostate cancer.
85 Background: The purpose of this study was to analyze skeletal events unrelated to bone metastasis in men with castration-refractory prostate cancer (CRPC). Methods: A total of 68 patients with CRPC treated by secondary hormonal therapy (dexamethasone) and/or chemotherapy including docetaxel were analyzed. Primary endpoint was skeletal related events (SREs) after PSA relapse. PSA relapse was defined as 3 consecutive PSA increase and serum PSA more than 4 ng/ml. Zoledronic acid was given for 31 patients with radiographic bone progression from the initiation of docetaxel-based treatment. For 37 patients without radiographic bone progression, no bone targeted agents or radioisotopes were administered during the observation period. Results: During median observation period of 17.5 months (range 1 to 76 months), SREs were observed in 17 of 68 patients (25%). In patients with bone progression, SREs was observed in 8 of 37 (22%) patients, whereas 9 of 31 (29%) patients without radiographic bone progression experienced SREs unrelated to bone metastasis. All patients without radiographic progression had been treated by oral steroids (dexamethasone), which might be related to osteoporotic change in these cases. Conclusions: For CRPC patients without radiographic bone progression, caution needs to be paid for SRE unrelated to bone metastasis. The administration of steroids may cause osteoporotic change, thus preventive administration of anti-osteoporotic agents would be mandatory.
- 10 February 2012
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 30 (5) , 85
Skeletal events unrelated to bone metastasis in men with castration-refractory prostate cancer.
85 Background: The purpose of this study was to analyze skeletal events unrelated to bone metastasis in men with castration-refractory prostate cancer (CRPC). Methods: A total of 68 patients with CRPC treated by secondary hormonal therapy (dexamethasone) and/or chemotherapy including docetaxel were analyzed. Primary endpoint was skeletal related events (SREs) after PSA relapse. PSA relapse was defined as 3 consecutive PSA increase and serum PSA more than 4 ng/ml. Zoledronic acid was given for 31 patients with radiographic bone progression from the initiation of docetaxel-based treatment. For 37 patients without radiographic bone progression, no bone targeted agents or radioisotopes were administered during the observation period. Results: During median observation period of 17.5 months (range 1 to 76 months), SREs were observed in 17 of 68 patients (25%). In patients with bone progression, SREs was observed in 8 of 37 (22%) patients, whereas 9 of 31 (29%) patients without radiographic bone progression experienced SREs unrelated to bone metastasis. All patients without radiographic progression had been treated by oral steroids (dexamethasone), which might be related to osteoporotic change in these cases. Conclusions: For CRPC patients without radiographic bone progression, caution needs to be paid for SRE unrelated to bone metastasis. The administration of steroids may cause osteoporotic change, thus preventive administration of anti-osteoporotic agents would be mandatory.
- 10 February 2012
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 30 (5) , 254
Use of radiographic progression to predict overall survival in men with castration-refractory prostate cancer.
254 Background: The purpose of this study was to analyze prognostic factors to predict overall survival in patients with castration-refractory prostate cancer (CRPC). Methods: A total of 68 patients with CRPC treated by secondary hormonal therapy (dexamethasone) and/or chemotherapy including docetaxel were analyzed. Primary endpoint was survival after PSA relapse. PSA relapse was defined as 3 consecutive PSA increase and serum PSA more than 4 ng/ml. Factors analyzed to predict survival were initial PSA value, initial clinical stage, pathological tumor grade (WHO grade), time to PSA relapse, nadir PSA value, time to nadir PSA, age at PSA relapse, PSA value at relapse, radiographic progression revealed by bone scan or CT scan, and bone pain. Univariate and multivariate analysis were performed using Cox regression hazard model. Results: Univariate analysis revealed nadir PSA value, time to nadir PSA, PSA value at relapse, radiographic progression revealed by bone scan or CT scan, and bone pain were significant predictors (p Conclusions: For patients with PSA relapse after hormonal therapy, the finding of radiographic progression was the only independent factor to predict overall survival.
- 10 February 2012
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 30 (5) , 254
Use of radiographic progression to predict overall survival in men with castration-refractory prostate cancer.
254 Background: The purpose of this study was to analyze prognostic factors to predict overall survival in patients with castration-refractory prostate cancer (CRPC). Methods: A total of 68 patients with CRPC treated by secondary hormonal therapy (dexamethasone) and/or chemotherapy including docetaxel were analyzed. Primary endpoint was survival after PSA relapse. PSA relapse was defined as 3 consecutive PSA increase and serum PSA more than 4 ng/ml. Factors analyzed to predict survival were initial PSA value, initial clinical stage, pathological tumor grade (WHO grade), time to PSA relapse, nadir PSA value, time to nadir PSA, age at PSA relapse, PSA value at relapse, radiographic progression revealed by bone scan or CT scan, and bone pain. Univariate and multivariate analysis were performed using Cox regression hazard model. Results: Univariate analysis revealed nadir PSA value, time to nadir PSA, PSA value at relapse, radiographic progression revealed by bone scan or CT scan, and bone pain were significant predictors (p Conclusions: For patients with PSA relapse after hormonal therapy, the finding of radiographic progression was the only independent factor to predict overall survival.
- Open Access
- 4 August 2011
- Published by Wiley in International Journal of Urology
- Vol. 18 (10) , 737
Response to Use of a combination of variables along with the PCA3 assay in better defining the “low risk” patient: A message from Pretoria to Kyoto
- 4 August 2011
- Published by Wiley in International Journal of Urology
- Vol. 18 (10) , 737
Open AccessResponse to Use of a combination of variables along with the PCA3 assay in better defining the “low risk” patient: A message from Pretoria to Kyoto
- 1 August 2011
- Vol. 57 (8) , 439-43
[Localized amyloidosis of the urinary bladder: a case report].
Amyloidosis is characterized by extracellular deposition of abnormal insoluble fibrils, which cause structural and functional disorders. Amyloidosis is classified into systemic and localized amyloidosis. Localized amyloidosis in individual organs is uncommon. We report a rare case of localized form of primary amyloidosis of the urinary bladder. A 76-year-old male visited our hospital with a complaint of macroscopic hematuria. Cystoscopy showed submucosal hematoma in the anterior wall and broad-based mass occupying the trigone without normal mucosa covered by calcification. Transurethral biopsy and resection were performed. Histopathological diagnosis was AL type amyloidosis occupying submucosal extracellular space. We gave the patient occlusive dressing with dimethyl sulfoxide. In 12 months, cystoscopy and magnetic resonance imaging revealed improvement of the mass-like lesion in the bladder wall.
- 1 August 2011
- Vol. 57 (8) , 439-43
[Localized amyloidosis of the urinary bladder: a case report].
Amyloidosis is characterized by extracellular deposition of abnormal insoluble fibrils, which cause structural and functional disorders. Amyloidosis is classified into systemic and localized amyloidosis. Localized amyloidosis in individual organs is uncommon. We report a rare case of localized form of primary amyloidosis of the urinary bladder. A 76-year-old male visited our hospital with a complaint of macroscopic hematuria. Cystoscopy showed submucosal hematoma in the anterior wall and broad-based mass occupying the trigone without normal mucosa covered by calcification. Transurethral biopsy and resection were performed. Histopathological diagnosis was AL type amyloidosis occupying submucosal extracellular space. We gave the patient occlusive dressing with dimethyl sulfoxide. In 12 months, cystoscopy and magnetic resonance imaging revealed improvement of the mass-like lesion in the bladder wall.
- 1 July 2011
- Published by Wolters Kluwer Health in Current Opinion in Urology
- Vol. 21 (4) , 303-308
Laparoendoscopic single-site surgery for pediatric patients in urology
Purpose of review Laparoendoscopic single-site surgery (LESS) has been increasingly reported to be a new less invasive approach. In the field of pediatric urology, in which even the application of laparoscopic surgery is still limited, recent studies are reviewed and the operative method and results evaluated. Recent findings Nephrectomy, nephroureterectomy and partial nephrectomy have been reported in renal surgery. Varicocelectomy, orchidectomy and orchidopexy have been performed for intrascrotal diseases. The postoperative complication of hematoma was observed in one bilateral case out of three nephrectomies, and blood transfusion and percutaneous drainage were needed. Postoperatively, two male patients out of 11 nephrectomy cases developed unilateral ipsilateral hydroceles. A surgical repair of the hydrocele was performed in a 3.9-year-old boy. Summary LESS for pediatric patients in urology is feasible but has just begun, and the number of cases experienced is still small. Further clinical evaluation including a large-scale study and comparison with standard laparoscopic surgery will reveal the true efficacy of this novel procedure.
- 1 July 2011
- Published by Wolters Kluwer Health in Current Opinion in Urology
- Vol. 21 (4) , 303-308
Laparoendoscopic single-site surgery for pediatric patients in urology
Purpose of review Laparoendoscopic single-site surgery (LESS) has been increasingly reported to be a new less invasive approach. In the field of pediatric urology, in which even the application of laparoscopic surgery is still limited, recent studies are reviewed and the operative method and results evaluated. Recent findings Nephrectomy, nephroureterectomy and partial nephrectomy have been reported in renal surgery. Varicocelectomy, orchidectomy and orchidopexy have been performed for intrascrotal diseases. The postoperative complication of hematoma was observed in one bilateral case out of three nephrectomies, and blood transfusion and percutaneous drainage were needed. Postoperatively, two male patients out of 11 nephrectomy cases developed unilateral ipsilateral hydroceles. A surgical repair of the hydrocele was performed in a 3.9-year-old boy. Summary LESS for pediatric patients in urology is feasible but has just begun, and the number of cases experienced is still small. Further clinical evaluation including a large-scale study and comparison with standard laparoscopic surgery will reveal the true efficacy of this novel procedure.
- Open Access
- 2 March 2010
- Published by Wiley in International Journal of Urology
- Vol. 17 (3) , 289-292
Laparoendoscopic single-site urological surgery: Initial experience in Japan
- 2 March 2010
- Published by Wiley in International Journal of Urology
- Vol. 17 (3) , 289-292
Open AccessLaparoendoscopic single-site urological surgery: Initial experience in Japan
- 1 November 2009
- Vol. 36 (12) , 2117-20
[Radio-frequency ablation (RFA) for post-chemotherapeutic metastatic germ cell tumors as minimally invasive salvage therapy].
Radio-frequency ablation (RFA) has been successfully applied for local control of metastatic tumor. The aim of this study was to assess the effectiveness and safety of RFA to post-chemotherapeutic metastatic germ cell tumors (GCTs). As combined modality therapy, RFA was performed to 42 tumors in 19 patients of GCTs at our institution between November 2000 and December 2008. RFA was performed for 10 liver metastatic tumors (in 6 cases), 32 lung metastatic tumors (in 13 cases), and median age was 36 years old (range 20-53) and the median tumor size was 12 mm (range 2-40). We used Cool-tip RF system (straight electrode needle of the internal cooling type, Radionics, Palm Coast, USA) for RFA with ultrasound or CT fluorosent guidance under intravenous or local anesthesia. The therapeutic effect was assessed by the contrast-enhanced CT or MRI. When contrast enhancement was remained in the tumor, the treatment was repeated. The 28 evaluable lesions followed were with median 25 months in the term of the surveillance, and 9 tumors were treated by an additional session of RFA repeatedly. complete response (CR) was achieved in 12 out of 12 tumors (100%) with tumor maker normalization. On the other hand, 12 out of 16 tumors (75%) without marker normalization showed CR. All of the 24 tumors with tumor diameter of 30 mm or less achieved CR, and the tumor greater than 30 mm achieved no CR. Major complications included pneumothorax (n=9) and hemato-thoraxes (n=2), but no complications in surrounding organs. The chest drainage tube was required in 4 cases (36%). RFA might be an alternative therapeutic option of combined modality therapy as salvage therapy for post-chemotherapeutic metastatic germ cell tumors.
- 1 November 2009
- Vol. 36 (12) , 2117-20
[Radio-frequency ablation (RFA) for post-chemotherapeutic metastatic germ cell tumors as minimally invasive salvage therapy].
Radio-frequency ablation (RFA) has been successfully applied for local control of metastatic tumor. The aim of this study was to assess the effectiveness and safety of RFA to post-chemotherapeutic metastatic germ cell tumors (GCTs). As combined modality therapy, RFA was performed to 42 tumors in 19 patients of GCTs at our institution between November 2000 and December 2008. RFA was performed for 10 liver metastatic tumors (in 6 cases), 32 lung metastatic tumors (in 13 cases), and median age was 36 years old (range 20-53) and the median tumor size was 12 mm (range 2-40). We used Cool-tip RF system (straight electrode needle of the internal cooling type, Radionics, Palm Coast, USA) for RFA with ultrasound or CT fluorosent guidance under intravenous or local anesthesia. The therapeutic effect was assessed by the contrast-enhanced CT or MRI. When contrast enhancement was remained in the tumor, the treatment was repeated. The 28 evaluable lesions followed were with median 25 months in the term of the surveillance, and 9 tumors were treated by an additional session of RFA repeatedly. complete response (CR) was achieved in 12 out of 12 tumors (100%) with tumor maker normalization. On the other hand, 12 out of 16 tumors (75%) without marker normalization showed CR. All of the 24 tumors with tumor diameter of 30 mm or less achieved CR, and the tumor greater than 30 mm achieved no CR. Major complications included pneumothorax (n=9) and hemato-thoraxes (n=2), but no complications in surrounding organs. The chest drainage tube was required in 4 cases (36%). RFA might be an alternative therapeutic option of combined modality therapy as salvage therapy for post-chemotherapeutic metastatic germ cell tumors.
- 1 November 2009
- Published by SAGE Publications in Journal of Endourology
- Vol. 23 (11) , 1875-1878
Transvesical Laparoscopic Cross-Trigonal Ureteral Reimplantation for Correction of Vesicoureteral Reflux: Initial Experience and Comparisons Between Adult and Pediatric Cases
Purpose: Transvesical laparoscopic cross-trigonal ureteral reimplantation (TLCUR) has been reported as an alternative procedure for vesicoureteral reflux mainly in pediatric cases. We review our initial experience with TLCUR and evaluate its feasibility in adult patients. Patients and Methods: We performed TLCUR in 30 patients (22 females and 24 bilateral cases) with a median age of 14.5 years. Results: The median operating time was 145 minutes in the unilateral cases and 230 minutes in the bilateral cases. Blood loss was minimal in all cases. No intraoperative complications were observed. The urethral catheter was removed at day 2 to 3. One persistence of reflux and one uretero-vesico anastomosis stricture were observed. The total success rate of 49 ureters in 27 patients, in whom postoperative cystography was performed, was 96% (47/49). Comparing the first 15 and last 15 cases, patient age was similar, the operation time was significantly shorter in the last 15 cases, and both operative failures were found in the first 15 cases. Comparing the 15 pediatric and 15 adult cases, the operation time did not differ between the two groups and one operative failure was observed in each group. Conclusion: This procedure was an effective and safe alternative minimally invasive procedure for both adult and pediatric patients with reflux.
- 1 November 2009
- Published by SAGE Publications in Journal of Endourology
- Vol. 23 (11) , 1875-1878
Transvesical Laparoscopic Cross-Trigonal Ureteral Reimplantation for Correction of Vesicoureteral Reflux: Initial Experience and Comparisons Between Adult and Pediatric Cases
Purpose: Transvesical laparoscopic cross-trigonal ureteral reimplantation (TLCUR) has been reported as an alternative procedure for vesicoureteral reflux mainly in pediatric cases. We review our initial experience with TLCUR and evaluate its feasibility in adult patients. Patients and Methods: We performed TLCUR in 30 patients (22 females and 24 bilateral cases) with a median age of 14.5 years. Results: The median operating time was 145 minutes in the unilateral cases and 230 minutes in the bilateral cases. Blood loss was minimal in all cases. No intraoperative complications were observed. The urethral catheter was removed at day 2 to 3. One persistence of reflux and one uretero-vesico anastomosis stricture were observed. The total success rate of 49 ureters in 27 patients, in whom postoperative cystography was performed, was 96% (47/49). Comparing the first 15 and last 15 cases, patient age was similar, the operation time was significantly shorter in the last 15 cases, and both operative failures were found in the first 15 cases. Comparing the 15 pediatric and 15 adult cases, the operation time did not differ between the two groups and one operative failure was observed in each group. Conclusion: This procedure was an effective and safe alternative minimally invasive procedure for both adult and pediatric patients with reflux.